Status:
UNKNOWN
Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease
Lead Sponsor:
Affiliated Hospital of Changchun University of Chinese Medicine
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
Compared with conventional treatment of the coronary heart disease,the aim of the research is to find out if the addition of Yangxinshi pills on the basis of conventional treatment can improve exercis...
Detailed Description
90 outpatients with clear diagnosis of coronary heart diseases will be recruited in the trial and randomized into two group. One group are treated with Yangxinshi pills (provided by Qingdao Growtful ...
Eligibility Criteria
Inclusion
- Age 40 \~ 75, gender is not limited
- Have a clear history or ECG of hospital myocardial infarction , diagnosed as coronary heart disease by imaging diagnosis
- Sign the informed consent voluntarily
Exclusion
- History of hospitalization for acute coronary syndrome in past 3 months
- Uncontrolled grade 3 hypertension（≥180/100mmHg）or hypotension（\<90/60mmHg）
- History of stroke (cerebral hemorrhage, subarachnoid hemorrhage, cerebral thrombosis, cerebral embolism and stroke of unknown type) or lower extremity arterial disease in the past 6 months
- In past 6 months, have medical history of: pregnancy, prepare or suspected of pregnancy, abortion, breastfeeding or after childbirth
- Combined episode bronchial asthma or chronic obstructive pulmonary disease, bradycardia (resting heart rate \<60bpm) or atrioventricular block
- Severely allergic constitution, known or likely to be allergic to the test drug or its components
- Known bleeding tendency or hemorrhagic disease
- Patients with severe liver and kidney dysfunction (creatinine clearance ≤ 40ml / min or in the active stage of kidney disease, serum aminotransferase ≥ 2 × upper limit of clinical reference), other life-threatening serious primary or psychiatric diseases and malignant tumors
- Any other situations that researchers believe may affect the clinical research
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 25 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03478332
Start Date
June 1 2017
End Date
August 25 2020
Last Update
March 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changchun Traditional Medicine University Affiliated Hospital
Changchun, Jilin, China, 130021